Adam Sharkawy is a co-founder of Material Impact who has leveraged his operational background as both an entrepreneur and Fortune 500 executive leader to build great companies. Through Material Impact’s first fund, Adam has led investments in Amastan Technologies, Fusion Coolant, NextGen Jane, and Orbion Space Technologies. He is on the Board of Directors of each company. In addition, he serves on the board of Soft Robotics.
Prior to Material Impact, Adam was Sr. Vice President of the Medicines Company and Head of their Surgery and Perioperative Care Global Business Unit. Before that, he served on the executive leadership team of Smith & Nephew, a leader in orthopedic implants, arthroscopic repair and sports medicine, and advanced wound care. Prior to that, he started the Advanced Healing Technologies / Biomaterials franchise within the Endoscopy division in the Boston area.
Adam was a member of the Abbott Vascular executive leadership team and served as their Vice President of Research and Advanced Development and New Ventures. Prior to Abbott Vascular, Adam helped start Ventrica, Inc., a privately held medical device company, and served as the Vice President of Research and Development until the acquisition of its technology by Medtronic. Prior to that, he served in several technology development roles for Heartport and Advanced Cardiovascular Systems.
Adam received his Ph.D. from Duke University in Biomedical Engineering and Biomaterials where he researched methods of growing small blood vessels around long term implants. He also holds a Master of Mechanical Engineering from Texas A&M. He received his Bachelor of Science in Mechanical Engineering from the American University, Cairo.